Association of treatment response with obesity and other metabolic risk factors in adults with depressive disorders: Results from a National Depression Cohort study in Korea (the CRESCEND study)

Young Sup Woo, Roger S. McIntyre, Jung Bum Kim, Min-Soo Lee, Jae Min Kim, Hyeon Woo Yim, Tae Youn Jun

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Available studies indicate that obesity may exert a moderational effect on antidepressant treatment response. The aim of this study was to investigate the relationship between treatment response and metabolic abnormalities amongst patients with depressive disorders in a large naturalistic clinical setting. Methods A nationwide prospective study was conducted in 18 hospitals in South Korea; 541 depressive patients meeting DSM-IV criteria were recruited. After baseline evaluation, subjects received naturalistic clinician-determined antidepressant interventions. Assessment was performed at baseline and weeks 1, 2, 4, 8, 12, 24 and 52. Treatment response was defined as a ≥50% reduction from baseline on at least one evaluation point. Results In univariate comparison, the patients who showed insufficient response to antidepressant therapy were more likely to be male, unmarried, unemployed, and obese. After adjusting for baseline variables, male sex (OR=1.82) and obesity (OR=1.55) remained as were significant variables. Stratification of the subjects into one of three groups, i.e. male, pre-menopausal female and post-menopausal female, revealed that males with concurrent metabolic problems, (i.e. the presence of one or more of hypertension, hyperglycemia, or hypercholesterolemia) had significantly higher risk for insufficient response (OR=2.32) and, after adjusting for baseline variables, obesity predicted insufficient response in post-menopausal female (OR=2.41). Conclusions The presence of metabolic abnormalities in patients with depressive disorders was associated with decreased treatment response to antidepressants. These results underscore the neurobiological relationship between obesity and the central nervous system, and provide empiric evidence supporting stratification of treatment response in depression.

Original languageEnglish
Pages (from-to)190-198
Number of pages9
JournalJournal of Affective Disorders
Volume203
DOIs
Publication statusPublished - 2016 Oct 1

Fingerprint

Korea
Depressive Disorder
Cohort Studies
Obesity
Depression
Antidepressive Agents
Therapeutics
Republic of Korea
Hypercholesterolemia
Diagnostic and Statistical Manual of Mental Disorders
Hyperglycemia
Central Nervous System
Prospective Studies
Hypertension

Keywords

  • Antidepressant
  • Depression
  • Gender difference
  • Menopause
  • Metabolic abnormalities
  • Treatment outcome

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Association of treatment response with obesity and other metabolic risk factors in adults with depressive disorders : Results from a National Depression Cohort study in Korea (the CRESCEND study). / Woo, Young Sup; McIntyre, Roger S.; Kim, Jung Bum; Lee, Min-Soo; Kim, Jae Min; Yim, Hyeon Woo; Jun, Tae Youn.

In: Journal of Affective Disorders, Vol. 203, 01.10.2016, p. 190-198.

Research output: Contribution to journalArticle

Woo, Young Sup ; McIntyre, Roger S. ; Kim, Jung Bum ; Lee, Min-Soo ; Kim, Jae Min ; Yim, Hyeon Woo ; Jun, Tae Youn. / Association of treatment response with obesity and other metabolic risk factors in adults with depressive disorders : Results from a National Depression Cohort study in Korea (the CRESCEND study). In: Journal of Affective Disorders. 2016 ; Vol. 203. pp. 190-198.
@article{cb986d850f2c4ba3aaba0ee43dbbda0f,
title = "Association of treatment response with obesity and other metabolic risk factors in adults with depressive disorders: Results from a National Depression Cohort study in Korea (the CRESCEND study)",
abstract = "Background Available studies indicate that obesity may exert a moderational effect on antidepressant treatment response. The aim of this study was to investigate the relationship between treatment response and metabolic abnormalities amongst patients with depressive disorders in a large naturalistic clinical setting. Methods A nationwide prospective study was conducted in 18 hospitals in South Korea; 541 depressive patients meeting DSM-IV criteria were recruited. After baseline evaluation, subjects received naturalistic clinician-determined antidepressant interventions. Assessment was performed at baseline and weeks 1, 2, 4, 8, 12, 24 and 52. Treatment response was defined as a ≥50{\%} reduction from baseline on at least one evaluation point. Results In univariate comparison, the patients who showed insufficient response to antidepressant therapy were more likely to be male, unmarried, unemployed, and obese. After adjusting for baseline variables, male sex (OR=1.82) and obesity (OR=1.55) remained as were significant variables. Stratification of the subjects into one of three groups, i.e. male, pre-menopausal female and post-menopausal female, revealed that males with concurrent metabolic problems, (i.e. the presence of one or more of hypertension, hyperglycemia, or hypercholesterolemia) had significantly higher risk for insufficient response (OR=2.32) and, after adjusting for baseline variables, obesity predicted insufficient response in post-menopausal female (OR=2.41). Conclusions The presence of metabolic abnormalities in patients with depressive disorders was associated with decreased treatment response to antidepressants. These results underscore the neurobiological relationship between obesity and the central nervous system, and provide empiric evidence supporting stratification of treatment response in depression.",
keywords = "Antidepressant, Depression, Gender difference, Menopause, Metabolic abnormalities, Treatment outcome",
author = "Woo, {Young Sup} and McIntyre, {Roger S.} and Kim, {Jung Bum} and Min-Soo Lee and Kim, {Jae Min} and Yim, {Hyeon Woo} and Jun, {Tae Youn}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.jad.2016.06.018",
language = "English",
volume = "203",
pages = "190--198",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

TY - JOUR

T1 - Association of treatment response with obesity and other metabolic risk factors in adults with depressive disorders

T2 - Results from a National Depression Cohort study in Korea (the CRESCEND study)

AU - Woo, Young Sup

AU - McIntyre, Roger S.

AU - Kim, Jung Bum

AU - Lee, Min-Soo

AU - Kim, Jae Min

AU - Yim, Hyeon Woo

AU - Jun, Tae Youn

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background Available studies indicate that obesity may exert a moderational effect on antidepressant treatment response. The aim of this study was to investigate the relationship between treatment response and metabolic abnormalities amongst patients with depressive disorders in a large naturalistic clinical setting. Methods A nationwide prospective study was conducted in 18 hospitals in South Korea; 541 depressive patients meeting DSM-IV criteria were recruited. After baseline evaluation, subjects received naturalistic clinician-determined antidepressant interventions. Assessment was performed at baseline and weeks 1, 2, 4, 8, 12, 24 and 52. Treatment response was defined as a ≥50% reduction from baseline on at least one evaluation point. Results In univariate comparison, the patients who showed insufficient response to antidepressant therapy were more likely to be male, unmarried, unemployed, and obese. After adjusting for baseline variables, male sex (OR=1.82) and obesity (OR=1.55) remained as were significant variables. Stratification of the subjects into one of three groups, i.e. male, pre-menopausal female and post-menopausal female, revealed that males with concurrent metabolic problems, (i.e. the presence of one or more of hypertension, hyperglycemia, or hypercholesterolemia) had significantly higher risk for insufficient response (OR=2.32) and, after adjusting for baseline variables, obesity predicted insufficient response in post-menopausal female (OR=2.41). Conclusions The presence of metabolic abnormalities in patients with depressive disorders was associated with decreased treatment response to antidepressants. These results underscore the neurobiological relationship between obesity and the central nervous system, and provide empiric evidence supporting stratification of treatment response in depression.

AB - Background Available studies indicate that obesity may exert a moderational effect on antidepressant treatment response. The aim of this study was to investigate the relationship between treatment response and metabolic abnormalities amongst patients with depressive disorders in a large naturalistic clinical setting. Methods A nationwide prospective study was conducted in 18 hospitals in South Korea; 541 depressive patients meeting DSM-IV criteria were recruited. After baseline evaluation, subjects received naturalistic clinician-determined antidepressant interventions. Assessment was performed at baseline and weeks 1, 2, 4, 8, 12, 24 and 52. Treatment response was defined as a ≥50% reduction from baseline on at least one evaluation point. Results In univariate comparison, the patients who showed insufficient response to antidepressant therapy were more likely to be male, unmarried, unemployed, and obese. After adjusting for baseline variables, male sex (OR=1.82) and obesity (OR=1.55) remained as were significant variables. Stratification of the subjects into one of three groups, i.e. male, pre-menopausal female and post-menopausal female, revealed that males with concurrent metabolic problems, (i.e. the presence of one or more of hypertension, hyperglycemia, or hypercholesterolemia) had significantly higher risk for insufficient response (OR=2.32) and, after adjusting for baseline variables, obesity predicted insufficient response in post-menopausal female (OR=2.41). Conclusions The presence of metabolic abnormalities in patients with depressive disorders was associated with decreased treatment response to antidepressants. These results underscore the neurobiological relationship between obesity and the central nervous system, and provide empiric evidence supporting stratification of treatment response in depression.

KW - Antidepressant

KW - Depression

KW - Gender difference

KW - Menopause

KW - Metabolic abnormalities

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=84974625177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84974625177&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2016.06.018

DO - 10.1016/j.jad.2016.06.018

M3 - Article

C2 - 27310099

AN - SCOPUS:84974625177

VL - 203

SP - 190

EP - 198

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -